Literature DB >> 10780285

Differential involvement of dopamine in mediating the discriminative stimulus effects of low and high doses of caffeine in rats.

K R Powell1, L F Koppelman, S G Holtzman.   

Abstract

The hypothesis that low and high doses of caffeine produce effects that are differentially mediated by dopamine (DA) receptor mechanisms was investigated in rats trained to discriminate either 10 or 56 mg/kg of caffeine from saline. Rats trained to discriminate 56 mg/kg of caffeine acquired the discrimination in an average of 74 sessions, whereas rats trained to discriminate 10 mg/kg of caffeine required an average of 108 sessions. The DA D1 receptor agonist SKF 81297 and the DA D2 receptor agonist R(-)-propylnorapomorphine (NPA) generalized partially (50-75%) in rats trained to discriminate 10 mg/kg of caffeine, but produced predominantly saline-appropriate responding (< 40%) in rats trained to discriminate 56 mg/kg of caffeine. When SKF 81297 and NPA were combined, stimulus generalization was no greater than it was when either agonist was tested alone. The DA uptake inhibitors cocaine and GBR 12909 produced predominantly saline-appropriate responding in both groups of rats. Neither the DA D1 receptors antagonists SCH 23390 and SCH 31966, nor the DA D2 receptor antagonists eticlopride and sulpiride, generalized in rats trained to discriminate 10 or 56 mg/kg of caffeine. When administered in combination with caffeine, both the DA D1 and DA D2 antagonists antagonized completely the discriminative stimulus effects of the low training dose of caffeine, but did not alter the discriminative stimulus effects of the high training dose. These results suggest that the discriminative stimulus effects of 10 mg/kg of caffeine, but not 56 mg/kg of caffeine, are dependent on, but not limited to, DA D1 and D2 receptor mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10780285     DOI: 10.1097/00008877-199912000-00001

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  11 in total

1.  ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex.

Authors:  Katharina Domschke; Agnieszka Gajewska; Bernward Winter; Martin J Herrmann; Bodo Warrings; Andreas Mühlberger; Katherina Wosnitza; Evelyn Glotzbach; Annette Conzelmann; Andrea Dlugos; Manfred Fobker; Christian Jacob; Volker Arolt; Andreas Reif; Paul Pauli; Peter Zwanzger; Jürgen Deckert
Journal:  Neuropsychopharmacology       Date:  2011-10-19       Impact factor: 7.853

2.  Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine.

Authors:  Gregory T Collins; Megan Abbott; Kayla Galindo; Elise L Rush; Kenner C Rice; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2016-08-04       Impact factor: 4.030

Review 3.  Role of training dose in drug discrimination: a review.

Authors:  Ian P Stolerman; Emma Childs; Matthew M Ford; Kathleen A Grant
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

4.  Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats.

Authors:  Marcello Solinas; Sergi Ferré; Katerina Antoniou; Davide Quarta; Zuzana Justinova; Jörg Hockemeyer; Lara A Pappas; Pavan N Segal; Carrie Wertheim; Christa E Müller; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

5.  The interoceptive Pavlovian stimulus effects of caffeine.

Authors:  Jennifer E Murray; Chia Li; Matthew I Palmatier; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

6.  Caffeine's Attenuation of Cocaine-Induced Dopamine Release by Inhibition of Adenosine.

Authors:  Lauren B Malave; Patricia A Broderick
Journal:  J Caffeine Res       Date:  2014-06-01

7.  Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential.

Authors:  John N Bain; Mark A Prendergast; Alvin V Terry; Stephen P Arneric; Mark A Smith; Jerry J Buccafusco
Journal:  Psychopharmacology (Berl)       Date:  2003-05-27       Impact factor: 4.530

8.  Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety.

Authors:  Emma Childs; Christa Hohoff; Jürgen Deckert; Ke Xu; Judith Badner; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2008-02-27       Impact factor: 7.853

9.  Discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) and structurally related synthetic cathinones.

Authors:  Robert W Seaman; Michelle R Doyle; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Behav Pharmacol       Date:  2021-08-01       Impact factor: 2.277

10.  Affect-modulated startle: interactive influence of catechol-O-methyltransferase Val158Met genotype and childhood trauma.

Authors:  Benedikt Klauke; Bernward Winter; Agnes Gajewska; Peter Zwanzger; Andreas Reif; Martin J Herrmann; Andrea Dlugos; Bodo Warrings; Christian Jacob; Andreas Mühlberger; Volker Arolt; Paul Pauli; Jürgen Deckert; Katharina Domschke
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.